Keywords:
митохондрии, митохондриальная дисфункция, психические расстройства, депрессия, биполярное аффективное расстройство, шизофрения, тревожные расстройства, клеточная биоэнергетика, оксидативный стресс, нейропластичность.References
1. Andreazza A.C., Kauer-Sant'Anna M., Frey B.N., et al. Oxidative stress markers in bipolar disorder: a meta-analysis // Journal of Affective Disorders. 2008. Vol. 111. No. 2–3. P. 135–144.
2. Berk M., Kapczinski F., Andreazza A.C., et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors // Neuroscience & Biobehavioral Reviews. 2011. Vol. 35. No. 3. P. 804–817.
3. Briston T., Hicks A.R. Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention // Biochemical Society Transactions. 2018. Vol. 46. No. 4. P. 829–842.
4. Chan D.C. Mitochondrial dynamics and its involvement in disease // Annual Review of Pathology: Mechanisms of Disease. 2020. Vol. 15. P. 235–259.
5. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain // Nature Reviews Neuroscience. 2008. Vol. 9. No. 1. P. 46–56.
6. Fattal O., Budur K., Vaughan A.J., Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases // Psychosomatics. 2006. Vol. 47. No. 1. P. 1–7.
7. Filograna R., Mennuni M., Alsina D., Larsson N.G. Mitochondrial DNA copy number in human disease: a systematic review // Cell. 2021. Vol. 184. No. 18. P. 4817–4834.
8. Fries G.R., Magalhães P.V., Kapczinski F. Neuroprogression and mitochondrial dysfunction in bipolar disorder // Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2014. Vol. 55. P. 130–139.
9. Grimm A., Eckert A. Brain aging and neurodegeneration: from a mitochondrial point of view // Journal of Neurochemistry. 2017. Vol. 143. No. 4. P. 418–431.
10. Kasahara T., Kato T. What can mitochondrial DNA analysis tell us about mood disorders? // Biological Psychiatry. 2018. Vol. 83. No. 9. P. 731–738.
11. Kato T. Mitochondrial dysfunction in bipolar disorder: from 31P magnetic resonance spectroscopy to intracellular calcium signaling // Journal of Affective Disorders. 2017. Vol. 223. P. 46–52.
12. Manji H.K., Quiroz J.A., Payne J.L., et al. The underlying neurobiology of bipolar disorder // World Psychiatry. 2003. Vol. 2. No. 3. P. 136–146.
13. Marchi S., Patergnani S., Pinton P. The endoplasmic reticulum-mitochondria connection: one touch, multiple functions // Biochimica et Biophysica Acta – Bioenergetics. 2018. Vol. 1859. No. 8. P. 589–598.
14. Martins-de-Souza D. Proteomics and metabolomics in schizophrenia: toward biomarkers and pathophysiological mechanisms // Journal of Proteomics. 2014. Vol. 97. P. 41–53.
15. McBride H.M., Neuspiel M., Wasiak S. Mitochondria: more than just a powerhouse // Current Biology. 2006. Vol. 16. No. 14. P. R551–R560.
16. Meyer J.N., Leung M.C.K., Rooney J.P., et al. Mitochondria as a target of environmental toxicants // Toxicological Sciences. 2013. Vol. 134. No. 1. P. 1–17.
17. Misgeld T., Schwarz T.L. Mitostasis in neurons: maintaining mitochondria in an extended cellular architecture // Neuron. 2017. Vol. 96. No. 3. P. 651–666.
18. Mitochondrial dysfunction in psychiatric disorders: mechanisms, biomarkers and therapeutic perspectives // Frontiers in Psychiatry. 2024. Vol. 15. Art. 1420892.
19. Modica-Napolitano J.S., Singh K.K. Mitochondria as targets for detection and treatment of cancer // Expert Reviews in Molecular Medicine. 2004. Vol. 6. No. 11. P. 1–19.
20. Morris G., Berk M., Maes M., Puri B.K. Could Alzheimer's disease originate in the periphery and if so, how so? Role of systemic inflammation and mitochondria // Molecular Neurobiology. 2019. Vol. 56. No. 1. P. 406–434.
21. Nunnari J., Suomalainen A. Mitochondria: in sickness and in health // Cell. 2012. Vol. 148. No. 6. P. 1145–1159.
22. Picard M., McEwen B.S. Psychological stress and mitochondria: a conceptual framework // Psychosomatic Medicine. 2018. Vol. 80. No. 2. P. 126–140.
23. Picard M., Wallace D.C., Burelle Y. The rise of mitochondria in medicine // Mitochondrion. 2016. Vol. 30. P. 105–116.
24. Rajasekaran A., Venkatasubramanian G., Berk M., Debnath M. Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications // Neuroscience & Biobehavioral Reviews. 2015. Vol. 48. P. 10–21.
25. Rango M., Bresolin N. Brain mitochondria, aging and Parkinson's disease // Genes. 2018. Vol. 9. No. 5. Art. 250.
26. Rezin G.T., Amboni G., Zugno A.I., et al. Mitochondrial dysfunction and psychiatric disorders // Neurochemical Research. 2009. Vol. 34. No. 6. P. 1021–1029.
27. Scaini G., Rezin G.T., Carvalho A.F., et al. Mitochondrial dysfunction in bipolar disorder: evidence, pathophysiology and translational implications // Neuroscience & Biobehavioral Reviews. 2016. Vol. 68. P. 694–713.
28. Spinelli J.B., Haigis M.C. The multifaceted contributions of mitochondria to cellular metabolism // Nature Cell Biology. 2018. Vol. 20. No. 7. P. 745–754.
29. Suomalainen A., Battersby B.J. Mitochondrial diseases: the contribution of organelle stress responses to pathology // Nature Reviews Molecular Cell Biology. 2018. Vol. 19. No. 2. P. 77–92.
30. Wallace D.C. Mitochondria and neurodegenerative diseases // Cold Spring Harbor Perspectives in Biology. 2012. Vol. 4. No. 2. a011403.
31. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer // Cold Spring Harbor Symposia on Quantitative Biology. 2005. Vol. 70. P. 485–497.
32. Wang W., Zhao F., Ma X., Perry G., Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances // Molecular Neurodegeneration. 2020. Vol. 15. Art. 30.
33. World Federation of Societies of Biological Psychiatry (WFSBP). Guidelines for biological treatment of mood disorders. Update 2023.
34. Yuan N., Chen Y., Xia Y., Dai J., Liu C. Inflammation-related biomarkers in major psychiatric disorders: a systematic review // Frontiers in Psychiatry. 2019. Vol. 10. Art. 692.
35. Zhao K., Zhang Q., Yu Z., et al. Mitochondrial dysfunction in psychiatric disorders: current evidence and therapeutic prospects // CNS Neuroscience & Therapeutics. 2024. Vol. 30. P. 1–18.
36. Zhang L., Trushina E., Christensen T.A., et al. Mitochondrial dysfunction in psychiatric disorders: mechanisms and therapeutic implications // Molecular Psychiatry. 2024. Vol. 29. P. 1642–1661.